- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2025–2030 · research · R37
Deciphering pathogenesis and therapeutic vulnerabilities in germline RUNX1 mutated AML
Wenbin Xiao · Kettering University · funded by National Institutes of Health
2025–2026 · cooperative agreement · UG1
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
Sheng Cai · Kettering University · funded by National Institutes of Health
2025–2030 · research · R35
Molecular mechanisms of protein function
Richard Kevin Hite · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
Chromatin architecture regulating trained immunity in antiviral NK cells
Joseph Chai-Yuen Sun · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
Role of the Cell Death Machinery in a Somatic Autoinflammatory Syndrome
Alexander Gitlin · Kettering University · funded by National Institutes of Health
2025–2029 · research · R35
Decoding the Ubiquitin and Autophagy Signaling Networks
Alban Ordureau · Kettering University · funded by National Institutes of Health
2025–2027 · career development · K99
Targeting the evolving immunopeptidome of metastatic colorectal cancer
Jaeyop Lee · Kettering University · funded by National Institutes of Health
2025–2028 · fellowship · F31
Interferon E as a Tumor Suppressor and Potential Therapeutic in Pancreatic Cancer
Isabella Del Priore · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Isoquercetin as a PDI inhibitor: dose-optimization and patient phenotyping
Robert C Flaumenhaft · Kettering University · funded by National Institutes of Health
2025–2030 · program · P01
Lipid Metabolism as a Determinant of Ferroptosis Sensitivity in Cancer
Xuejun Jiang · Kettering University · funded by National Institutes of Health
2025–2030 · research · R35
Mechanisms of energy storage in lipid droplets
Robert V Farese · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Practical Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL)
Veronica Miriam Rotemberg · Kettering University · funded by National Institutes of Health
2025–2026 · cooperative agreement · U01
Comparative Modeling of Effective Policies for Colorectal Cancer Control
Carolyn M Rutter · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Antigen-specific radiosensitization
Daniel Higginson · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
The Role of EP300 Mutations in Bladder Cancer Pathogenesis and Drug Response
Gopa Iyer · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
The Genetic Epidemiology of Radiation-Associated Contralateral Breast Cancer
Jonine L. Bernstein · Kettering University · funded by National Institutes of Health
2025–2030 · research · R37
Myeloma Defining Genomic Events to Differentiate Benign and Malignant Myeloma Precursor Conditions
Francesco Maura · Kettering University · funded by National Institutes of Health
2025–2029 · research · R01
TYK2 Fusions in Lymphoma
Kojo S. J. Elenitoba-Johnson · Kettering University · funded by National Institutes of Health
2025–2032 · research · R35
Overcoming Resistance to Targeted Therapy in Breast Cancer
Sarat Chandarlapaty · Kettering University · funded by National Institutes of Health
2025–2030 · research · R01
Improving CDK4/6 inhibition therapy for patients with liposarcoma by understanding resistance
Cristina R Antonescu · Kettering University · funded by National Institutes of Health
2025–2030 · program · P01
Project 1: Phospholipid Remodeling in Ferroptosis and Cancer
Xuejun Jiang · Kettering University · funded by National Institutes of Health
2025–2030 · program · P01
Administrative Core
Xuejun Jiang · Kettering University · funded by National Institutes of Health
2025–2030 · program · P01
Project 3: PHLDA2-mediated Phospholipid Oxidation in Ferroptosis and Tumor Suppression
Wei Gu · Kettering University · funded by National Institutes of Health
2025–2030 · program · P01
Project 2: Targeting Specific Lipid Species that Drive Ferroptosis Resistance
Brent R. Stockwell · Kettering University · funded by National Institutes of Health
2025–2030 · program · P01
Shared Resources Core: Ferroptosis Biomarkers and Lipidomic Analysis
Brent R. Stockwell · Kettering University · funded by National Institutes of Health
2024–2028 · research · R01
Structural basis of eukaryotic clamp loading
Richard Kevin Hite · Kettering University · funded by National Institutes of Health
2024–2027 · cooperative agreement · U01
Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers
Alex Kentsis · Kettering University · funded by U.S. Food and Drug Administration
2024–2026 · career development · K99
WNK1-dependent macropinocytosis mediates emergency myelopoiesis
Alissa Jane Trzeciak · Kettering University · funded by National Institutes of Health
2024–2026 · research · R21
Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial
Gary E Deng · Kettering University · funded by National Institutes of Health
2024–2025 · research · R13
7th Annual Workshop on Confocal Microscopy for Cutaneous Diagnostics
Manu Jain · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Neoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal Cancer
Andrea Cercek · Kettering University · funded by National Institutes of Health
2024–2026 · research · R21
Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging
Mark Thomas Burgess · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Maternal B cells in health and disease.
Gabrielle A Rizzuto · Kettering University · funded by National Institutes of Health
2024–2026 · research · R01
Interrogation of the oxidative-stress-induced leukemia program in vivo usingmetabolic imaging
Kayvan R Keshari · Kettering University · funded by National Institutes of Health
2024–2029 · research · R37
Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation
Xiang Shu · Kettering University · funded by National Institutes of Health
2024–2029 · program · P01
Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal niche
Richard John Bennett · Kettering University · funded by National Institutes of Health
2024–2025 · grant · D43
Administrative supplement to expand cancer clinical trial capacity in sub-Saharan Africa
Olusegun Isaac Alatise · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Mechanistic basis for endoplasmic reticulum-driven cytoprotection by selective autophagy in neurons
Alban Ordureau · Kettering University · funded by National Institutes of Health
2024–2027 · fellowship · CIHR Fellowship
Three-dimensional spatial annotation of single-cell transcriptome using multiplexed imaging of the midgestational gut tube
Mohamed Gatie · Kettering University · funded by Canadian Institutes of Health Research
2024–2027 · grant · Continuing Grant
Collaborative Research: Illumination of Smc5/6 management of DNA repair intermediate structures
Xiaolan Zhao · Kettering University · funded by National Science Foundation